Dr. Ryan Michaud, MD
What this data tells you about Dr. Michaud
Dr. Ryan Michaud is an anesthesiology in Seguin, TX, with 19 years in practice. Based on federal Medicare data, Dr. Michaud performed 3,311 Medicare services across 1,500 unique beneficiaries.
Between the years covered by Open Payments, Dr. Michaud received a total of $37,825 from 45 pharmaceutical and/or device companies across 2130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Michaud is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test | 941 | $60 | $600 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 752 | $192 | $600 |
| Office visit, established patient (30-39 min) | 385 | $92 | $380 |
| Dexamethasone injection (steroid) | 285 | $0 | $3 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 177 | $239 | $750 |
| Assessment of emotional or behavioral problems | 135 | $4 | $17 |
| Insertion of spinal neurostimulator electrode array through skin | 56 | $239 | $6,649 |
| Injection, ketorolac tromethamine, per 15 mg | 48 | $0 | $6 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 42 | $59 | $270 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 39 | $105 | $526 |
| New patient office visit (45-59 min) | 39 | $114 | $490 |
| Office visit, established patient (20-29 min) | 36 | $63 | $267 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 33 | $73 | $290 |
| Compounded drug, not otherwise classified | 32 | $183 | $289 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 31 | $67 | $517 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 30 | $120 | $573 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 30 | $225 | $1,245 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 28 | $100 | $735 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 26 | $84 | $489 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 26 | $69 | $289 |
| Joint injection, major joint | 21 | $33 | $187 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 19 | $68 | $567 |
| Drug injection, under skin or into muscle | 19 | $11 | $41 |
| Fluoroscopic guidance for needle placement | 18 | $21 | $342 |
| Insertion of spinal neurostimulator generator or receiver | 17 | $185 | $1,051 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 17 | $213 | $1,257 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $47 | $330 |
| Injection of substance into middle or upper spine canal using imaging guidance | 14 | $83 | $798 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for anesthesiology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Michaud is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Michaud experienced with drug screening test?
Does Dr. Michaud receive payments from pharmaceutical companies?
How do Dr. Michaud's costs compare to other anesthesiologys in Seguin?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology